These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2170673)

  • 1. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.
    Sato H; Takimoto T; Tanaka S; Tanaka J; Raab-Traub N
    J Virol; 1990 Nov; 64(11):5295-300. PubMed ID: 2170673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS; Tran VM
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA.
    Zimmermann J; Hammerschmidt W
    J Virol; 1995 May; 69(5):3147-55. PubMed ID: 7707542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.
    Raab-Traub N; Flynn K
    Cell; 1986 Dec; 47(6):883-9. PubMed ID: 3022942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circular intracellular form of Epstein-Barr virus DNA is amplified by the virus-associated DNA polymerase.
    Shaw JE
    J Virol; 1985 Mar; 53(3):1012-5. PubMed ID: 2983082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular state of Epstein-Barr virus DNA in producer cell lines.
    Gussander E; Adams A
    J Gen Virol; 1979 Nov; 45(2):331-40. PubMed ID: 232128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
    Gradoville L; Grogan E; Taylor N; Miller G
    Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.
    Hurley EA; Klaman LD; Agger S; Lawrence JB; Thorley-Lawson DA
    J Virol; 1991 Jul; 65(7):3958-63. PubMed ID: 1645805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedimentation characteristics of newly synthesized Epstein-Barr viral DNA in superinfected cells.
    Siegel PJ; Clough W; Strominger JL
    J Virol; 1981 Jun; 38(3):880-5. PubMed ID: 6264162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.
    Colby BM; Shaw JE; Elion GB; Pagano JS
    J Virol; 1980 May; 34(2):560-8. PubMed ID: 6246281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal Repeat Analysis of EBV Genomes.
    Bánáti F; Koroknai A; Szenthe K
    Methods Mol Biol; 2017; 1532():169-177. PubMed ID: 27873275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
    Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
    Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    King W; Thomas-Powell AL; Raab-Traub N; Hawke M; Kieff E
    J Virol; 1980 Nov; 36(2):506-18. PubMed ID: 6253674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus replication in oropharyngeal epithelial cells.
    Sixbey JW; Nedrud JG; Raab-Traub N; Hanes RA; Pagano JS
    N Engl J Med; 1984 May; 310(19):1225-30. PubMed ID: 6323983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
    Sato H; Takimoto T; Pagano JS; Raab-Traub N
    J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
    Katz BZ; Raab-Traub N; Miller G
    J Infect Dis; 1989 Oct; 160(4):589-98. PubMed ID: 2551973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Gahn TA; Schildkraut CL
    Cell; 1989 Aug; 58(3):527-35. PubMed ID: 2547525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.